STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Larimar Therapeutics, Inc.

Filed

May 12, 2022

Period of Report

May 10, 2022

Accession Number

0001062993-22-012309